ResearcherChinese PLA General HospitalActive in the last 2 years
Mingzhou Guo
Matched on ORCID iD 0000-0002-9445-9984; OpenAlex author ID A5083607904. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 5
- L3MBTL4 methylation is a sensitive marker of DNA-PK inhibitor in pancreatic cancer. Last author DOI 10.37349/etat.2026.1002382↗
- Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling. Last author DOI 10.1080/15384047.2024.2302924↗
- Methylation of FAM110C is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer. Last author DOI 10.2478/jtim-2023-0128↗
- Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancer. First author DOI 10.1111/cas.14565↗
- Gd-Metallofullerenol Nanomaterial Suppresses Pancreatic Cancer Metastasis by Inhibiting the Interaction of Histone Deacetylase 1 and Metastasis-Associated Prot… Co-author DOI 10.1021/nn506782f↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuanxin Yao · 1 shared paper, 2026 · strength 0.30
- Qian Du · 1 shared paper, 2024 · strength 0.28
- Fengna Liu · 1 shared paper, 2024 · strength 0.24
- Fan Zhang · 1 shared paper, 2024 · strength 0.24
- Yunlong Hu · 1 shared paper, 2020 · strength 0.24
- Yuanming Pan · 1 shared paper, 2015 · strength 0.05
- Yuliang Zhao · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.